Patent 8685897 was granted and assigned to AnaptysBio on April, 2014 by the United States Patent and Trademark Office.
This invention relates to methods for the generation of humanized antibodies, particularly a humanized antibody heavy chain protein and a humanized antibody light chain protein. The method comprises using cells that express or can be induced to express Activation Induced Cytidine Deaminase (AID).